Leo Innovation Lab says sale of spinoff is "stamp of approval"

The sale of healthcare app company Omhu to US-based Medable is the first time that Leo Innovation Lab has completely let go of one of its companies. CEO Anne Cathrine Fleischer sees the sale as a stamp of approval.
Anne Cathrine Fleischer, CEO at Leo Innovation Lab | Photo: Mathilde Gilling / Leo Innovation Lab / PR
Anne Cathrine Fleischer, CEO at Leo Innovation Lab | Photo: Mathilde Gilling / Leo Innovation Lab / PR
by ANDREAS LØNSTRUP, translated by catherine brett & daniel pedersen

Just two years after app company Omhu was spun out from Leo Innovation Lab, Leo has chosen to sell all of its shares in the firm to US-based Medable for an undisclosed sum. It is the first time that Leo Innovation Lab has sold the entirety of one of its spinoff companies.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading